GL1X · GenesisL1 explorer

MolNFT v1 · #111552 · protein

Crystal structure of bacillus anthracis immune inhibitor A2 peptidase zymogen

4YU6 · Immune inhibitor a, metalloprotease: “Crystal structure of bacillus anthracis immune inhibitor A2 peptidase zymogen”. X-ray diffraction, 5 ligands (CCN, CA, ZN), 14 pockets (best druggability 0.86). MolNFT v1 #111552 on GenesisL1…

PDB
4YU6
Type
protein
Length
1,462 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Immune inhibitor a, metalloprotease
EC
3.4.24.-
UniProt
D8H130
Ligands
CCN, CA, ZN, NA, K
Pockets
14 · best druggability 0.86

Structure

x-ray diffraction · 2 distinct chains · 18% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AImmune inhibitor a, metalloprotease (EC 3.4.24.-)protein75418% helix, 28% strandD8H130
BImmune inhibitor a, metalloprotease (EC 3.4.24.-)protein70818% helix, 30% strandD8H130

Ligands and binding sites

  • CCN · Acetonitrile · ligand · 3 copies · chains A, B
  • CA · Calcium ion · metal · 9 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • NA · Sodium ion · metal · 2 copies · chains A
  • K · Potassium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111520.860.88112empty
25220.830.8947empty
34560.810.8852empty
4800.730.9735CCN
52070.600.8136empty

Interfaces

1 interface between chains.

  • A–B · 112 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 4YU6 · Crystal structure of Bacillus anthracis immune inhibitor A2 peptidase zymogen · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.